help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Related articles in Am J Pathol
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sieben, N. L.G.
Right arrow Articles by Fleuren, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sieben, N. L.G.
Right arrow Articles by Fleuren, G. J.
(American Journal of Pathology. 2003;162:1095-1101.)
© 2003 American Society for Investigative Pathology

Molecular Genetic Evidence for Monoclonal Origin of Bilateral Ovarian Serous Borderline Tumors

Nathalie L.G. Sieben*, Sandra M. Kolkman-Uljee*, Adrienne M. Flanagan{dagger}, Saskia le Cessie{ddagger}, Anne-Marie Cleton-Jansen*, Cees J. Cornelisse* and Gert Jan Fleuren*

From the Departments of Pathology* and Medical Statistics,{ddagger} the University Medical Center, Leiden, The Netherlands; and University College London Medical School,{dagger} London, United Kingdom

Patients with serous borderline tumors of the ovary often present with multiple tumors at different sites in the abdominal cavity. Whether different foci of ovarian serous borderline tumors are monoclonal in origin, arising as a consequence of spread from a single ovarian site, or whether such deposits are polyclonal and explained by independent molecular genetic alterations on the background of a field defect, is unknown. So far, only X-chromosome inactivation studies were performed to study this issue. We used a genome-wide allelotyping to assess clonality in 47 metachronous and/or synchronous multifocal tumors from 22 patients, using 59 microsatellite markers. Loss of heterozygosity (LOH) was observed in only 34 of 1969 informative markers in 9 of 22 serous borderline cases studied. Of these cases, 7 showed concordant LOH for at least one polymorphic marker in more than one tumor site. Flanking microsatellite markers enabled identification of identical chromosomal breakpoints in 6 of 7 cases. The LOH results strongly favor a common origin indicated by a likelihood ratio (possibility common origin/possibility independent origin) ranging from 39 to 14,163. Strong additional evidence for monoclonality is provided by the finding of identical microsatellite alterations in all three-tumor sites in one case.


Related articles in Am J Pathol:

Corrections

Am J Pathol 2006 168: 714. [Full Text]  



This article has been cited by other articles:


Home page
 INT J SURG PATHOLHome page
S. Bhagavathi and C.-H. Chang
Multicentric Basaloid Carcinoma of Lung Clinically Mimicking Metastatic Carcinoma: A Case Report
International Journal of Surgical Pathology, February 1, 2009; 17(1): 68 - 71.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society for Investigative Pathology.